Get started
Author

Yuheng Pang

The hepatitis B virus promotes the progression of non-alcoholic fatty liver disease through incomplete autophagy
2023 · Yang Wang, Jiaxi Li, et al. · Free Radical Biology and Medicine · 36
High-Dimensional Immune Profiling by Mass Cytometry Revealed the Circulating Immune Cell Landscape in Patients With Intracranial Aneurysm
2022 · Peicong Ge, Chenglong Liu, et al. · Frontiers in Immunology · 32
Genistein-induced mitochondrial dysfunction and FOXO3a/PUMA expression in non-small lung cancer cells
2022 · Liujia Chan, Yuheng Pang, et al. · Pharmaceutical Biology · 28
Caffeic acid inhibits the tumorigenicity of triple-negative breast cancer cells through the FOXO1/FIS pathway
2024 · Chufei Xie, Liujia Chan, et al. · Biomedicine & Pharmacotherapy · 26
Rosmarinic acid promotes mitochondrial fission and induces ferroptosis in triple-negative breast cancer cells
2025 · Chufei Xie, Liujia Chan, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 21
Highly-tumor-targeted PAD4 inhibitors with PBA modification inhibit tumors in vivo by specifically inhibiting the PAD4-H3cit-NETs pathway in neutrophils
2023 · Di Zhu, Yu Lu, et al. · European Journal of Medicinal Chemistry · 21
The combination of the HDAC1 inhibitor SAHA and doxorubicin has synergic efficacy in triple negative breast cancer in vivo
2023 · Yuheng Pang, Runze Shi, et al. · Pharmacological Research · 19
Cancer stem cells promote lymph nodes metastasis of breast cancer by reprogramming tumor microenvironment
2023 · Lin Li, Jianyu Liu, et al. · Translational Oncology · 13
Innate Immune Cell Profiling in Peripheral Blood Mononuclear Cells of Patients with Moyamoya Disease
2024 · Chenglong Liu, Siqi Mou, et al. · Inflammation · 12
Targeting mitochondrial dynamics by AZD5363 in triple-negative breast cancer MDA-MB-231 cell–derived spheres
2023 · Yingqiang Fu, Wei Dong, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 12
PDF
Zonated Copper‐Driven Breast Cancer Progression Countered by a Copper‐Depleting Nanoagent for Immune and Metabolic Reprogramming
2025 · Lin Chen, Saibo Ma, et al. · Advanced Science · 10
PDF
Circulating T cell atlas in Moyamoya disease: insights into immunopathogenesis of cerebrovascular disorders
2025 · Chenglong Liu, Junsheng Li, et al. · Journal of Neuroinflammation · 6
PDF
Single-Cell Proteomic Profiling Identifies Nanoparticle Enhanced Therapy for Triple Negative Breast Cancer Stem Cells
2021 · Wenzheng Wang, Bo Lei, et al. · Cells · 6
PDF
Mass cytometry revealed the circulating immune cell landscape across different Suzuki stages of Moyamoya disease
2024 · Chenglong Liu, Peicong Ge, et al. · Immunologic Research · 5
PDF
Mitosis targeting in non-small lung cancer cells by inhibition of PAD4
2024 · Xiangmei Wu, Liujia Chan, et al. · Heliyon · 4
Application of mass cytometry in the immune microenvironment of breast cancer
2025 · Yuefeng Shang, Yuheng Pang, et al. · Medical Oncology · 2
Integrated bulk RNA sequencing and mass cytometry analysis reveal the circulating immune landscape in ischemic and hemorrhagic Moyamoya disease
2025 · Chenglong Liu, Peicong Ge, et al. · BMC Immunology · 2
CyTOF analysis revealed platelet heterogeneity in breast cancer patients received T-DM1 treatment
2024 · Jianli Ma, Yuheng Pang, et al. · Clinical Immunology · 2
Immune-metabolic profiling of triple-negative breast cancer during neoadjuvant chemotherapy
2026 · Runze Shi, Yuheng Pang, et al. · iScience · 1
T cells immune imbalance presents in patients with multiple intracranial aneurysms
2024 · Chuming Tao, Chenglong Liu, et al. · Clinical & Experimental Immunology · 1
PDF
mRNA sequencing and CyTOF analysis revealed ASPP2 altered the response patterns of hepatocellular carcinoma HepG2 cells to usnic acid
2023 · Yang Wang, Yadong Yan, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1
Multi‐Omics Integration Reveals Metabolic Reprogramming and EMT ‐Driven Metastasis in Triple‐Negative Breast Cancer
2026 · Yuheng Pang, Yuefeng Shang, et al. · Cancer Science
Activated platelets stimulate effector CD8+ T cells to enhance HNSCC immunotherapy efficacy
2025 · Zhennan Yuan, Lunhua Guo, et al. · Discover Oncology
Works count: 27
Citation count: 260
H-index: 10
I10-index: 11
Year
Topic
Type